SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging alongside other semiconductor leaders as strong CPU performance data from Intel drives sector-wide momentum and investor FOMO. The community is actively debating whether this parabolic rally is a sustainable AI-driven breakout or an overextended bubble, with many traders focused on short squeezes and aggressive price action.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors react to the company's expanding role in AI infrastructure, specifically following confirmation of orders linked to Marvell and potential integration into hyperscale ecosystems. The community is actively celebrating a significant short squeeze, with many long-term shareholders highlighting the company's move from R&D to commercial execution as a major long-term catalyst.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is experiencing significant volatility and downward pressure as shareholders react to a recent shelf offering and concerns over clinical trial timelines. While the community remains polarized, with some investors accumulating shares on dips anticipating future trial data and a potential short squeeze, others are expressing frustration over the persistent selling and lack of clear upward momentum.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as retail investors react to a recent convertible notes offering, which triggered short-term volatility despite analysts viewing it as a move to strengthen the company's balance sheet for long-term R&D. The community remains deeply divided, with many long-term holders expressing frustration over price stagnation and leadership execution, while others highlight the company's $2 billion cash pile and upcoming clinical data catalysts as reasons to remain bullish.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing intense volatility and record-breaking momentum, with community debate centered on whether this surge represents a sustainable AI-driven growth cycle or a speculative bubble reminiscent of the dot-com era. Traders are actively discussing the extreme technical overextension and concentration of the trade, with many weighing the risks of a blow-off top against the potential for continued upside from data center demand.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) has captured significant community attention due to its historic streak of consecutive green sessions and parabolic price action, prompting intense debate over whether it represents a sustainable AI-driven bull run or an overdue blow-off top. Investors are actively discussing the risks of extreme overbought conditions while weighing tactical hedging strategies, such as using inverse ETFs, against a bullish narrative centered on unrelenting demand for AI infrastructure.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing a sharp sell-off as investors react to margin concerns and geopolitical headwinds, despite the company beating revenue expectations and raising its AI-driven growth targets. Community sentiment is deeply divided between long-term investors viewing the pullback as a generational buying opportunity and traders expressing frustration over extreme volatility and the broader rotation of capital away from enterprise software.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as retail investors speculate that Founder Patrick Soon-Shiong's ongoing trip to Japan signals a significant upcoming international partnership or distribution deal. The community remains divided between long-term holders optimistic about global commercial expansion and vocal traders frustrated by persistent price volatility and recent legal headlines.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ituran Location and Control (NASDAQ:ITRN) Sets New 52-Week High - Here's Why

Ituran Location and Control (NASDAQ:ITRN) Reaches New 12-Month High - Here's What Happened...

Short Interest in Ituran Location and Control Ltd. (NASDAQ:ITRN) Expands By 18.6%

Ituran Location and Control Ltd. (NASDAQ:ITRN - Get Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totaling 144,480 shares, a growth of...

J.M. Arbour LLC Takes $881,000 Position in Ituran Location and Control Ltd. $ITRN

J.M. Arbour LLC purchased a new stake in Ituran Location and Control Ltd. (NASDAQ:ITRN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The...

Ituran Location and Control (NASDAQ:ITRN) Reaches New 52-Week High  - Time to Buy?

Ituran Location and Control (NASDAQ:ITRN) Reaches New 1-Year High - Time to Buy...

Ituran Location and Control (NASDAQ:ITRN) Upgraded to "Strong-Buy" at Wall Street Zen

Wall Street Zen upgraded shares of Ituran Location and Control from a "buy" rating to a "strong-buy" rating in a research note on Sunday...

Ituran Location and Control (NASDAQ:ITRN) Sets New 52-Week High - Should You Buy?

Ituran Location and Control (NASDAQ:ITRN) Sets New 1-Year High - Still a Buy...

Y.D. More Investments Ltd Acquires 39,718 Shares of Ituran Location and Control Ltd. $ITRN

Y.D. More Investments Ltd increased its holdings in Ituran Location and Control Ltd. (NASDAQ:ITRN - Free Report) by 4.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 858,274 shares of the industrial prod...

Ituran Location and Control (NASDAQ:ITRN) Cut to "Buy" at Wall Street Zen

Wall Street Zen lowered shares of Ituran Location and Control from a "strong-buy" rating to a "buy" rating in a research note on Saturday...

Short Interest in Ituran Location and Control Ltd. (NASDAQ:ITRN) Drops By 16.7%

Ituran Location and Control Ltd. (NASDAQ:ITRN - Get Free Report) saw a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 121,830 shares, a decline of 16.7% from the February 26th total of 146,207 shares. Based on an average trading...

Ituran Location and Control (NASDAQ:ITRN) Sets New 1-Year High - Should You Buy...

Ituran Location & Control Ltd. engages in the provision of stolen vehicle recovery, fleet management, and tracking services. It operates through the Telematics Services and Telematics Products segments. The Telematics Services segment consists of regionally- based stolen vehicle recovery services, fleet management services, and value-added services that include among others, connected cars, UBI, personal advanced locater services, and concierge services. The Telematics Products segment focuses on short and medium range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. The company was founded by Yehuda Kahane, Eyal Sheratzky and Izzy Sheratzky in February 1994 and is headquartered in Azour, Israel.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.79	--	--	N/A
Q4 '25	$0.75	$0.77	2.39%	BEAT
Q3 '25	$0.69	$0.74	7.09%	BEAT
Q2 '25	$0.71	$0.67	-5.63%	MISSED
Q1 '25	$0.69	$0.73	6.57%	BEAT

ITRN
Ituran Location And Control Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ITRN News

ITRNIturan Location And Control Ltd.